Pronóstico del mercado europeo de administración de fármacos oculares hasta 2028: impacto de COVID-19 y análisis regional por tecnología (sistemas de administración de fármacos oculares implantables, sistemas de administración de fármacos en partículas, sistema de administración de fármacos en nanopartículas y otros), tipo de formulación (liposomas y nanopartículas, solución, Emulsión, suspensión y ungüento), tipo de enfermedad (glaucoma, retinopatía diabética, síndrome de ojo seco, degeneración macular, cataratas, edema macular diabético y otras) y usuario final (hospitales, clínicas oftálmicas y centros de cirugía ambulatoria)

Introducción al mercado

El mercado europeo de administración de fármacos oculares está segmentado en Alemania, Reino Unido, Francia, Italia, España y el resto de Europa. y Alemania tenía la mayor participación en el mercado. La creciente población geriátrica de Alemania representa una oportunidad lucrativa para una mayor adopción del mercado de administración de fármacos oculares en el país. Según el Programa de preparación y preparación para el envejecimiento. Según la Iniciativa de Competitividad, se prevé que la población de Alemania de 65 años o más crecerá un 41% hasta alcanzar los 24 millones en 2050, lo que representará casi un tercio de la población total. Además, un gran número de pacientes que viven con trastornos oculares están impulsando el crecimiento del mercado. Según el Instituto Europeo de la Visión EEIG, en Alemania unas 30.000 personas padecían enfermedades hereditarias de la retina. La creciente digitalización y el uso extensivo de pequeños dispositivos móviles han provocado problemas de visión a edades más tempranas, lo que ha impulsado las ventas de lentes de contacto. Además, el país cuenta con un sólido soporte tecnológico para dispositivos médicos; el país cuenta con varias empresas que se dedican a trabajar en dispositivos médicos sofisticados. Además, es probable que la presencia de actores del mercado en el país aumente el conocimiento y el alcance del producto en el mercado. Novaliq es una empresa farmacéutica oftálmica alemana y está desarrollando la primera tecnología sin agua para la administración de fármacos oculares. Novaliq se centra en desarrollar tecnología para su uso en tratamientos para la enfermedad del ojo seco. Los productos de la empresa se centran en su tecnología patentada sin agua, EyeSol, para la administración de fármacos oculares tópicos.

La región europea se ha visto enormemente afectada por la propagación del COVID-19, y la mayoría de los países están bloqueados. Se cancelaron los servicios de atención médica de rutina y se recomendó a los pacientes que evitaran las visitas al hospital para minimizar el riesgo de transmisión de COVID-19, lo que provocó una interrupción significativa en la prestación del servicio de atención médica y la atención al paciente. La oftalmología representa una de las especialidades más concurridas y más orientadas a los pacientes ambulatorios, con alrededor de 7,5 millones de citas ambulatorias y más de 500.000 procedimientos quirúrgicos que se realizan cada año en el Reino Unido. El confinamiento ha provocado la cancelación de miles de visitas y cirugías oftálmicas; Esto puede provocar un daño permanente y significativo a la visión del paciente. Además, según la encuesta reciente, – ‘Impacto psicosocial del bloqueo pandémico de COVID-19 en las personas que viven con enfermedades oculares en el Reino Unido’ que se llevó a cabo entre el público con enfermedades oculares, destacó un impacto psicosocial negativo significativo del encierro en los pacientes con discapacidad visual, con aproximadamente el 50% de los pacientes expresando miedo a perder la visión debido a un retraso en la revisión o el tratamiento.

Descripción general y dinámica del mercado

Se espera que el mercado de administración de medicamentos oculares en Europa crezca 7.921,15 millones de dólares para 2028 desde 4.967,64 millones de dólares en 2021. Se estima que el mercado crecerá a una tasa compuesta anual del 6,9% de 2021 a 2028. Las cataratas, el glaucoma, la degeneración macular relacionada con la edad, la retinopatía diabética y los errores refractivos no tratados se encuentran entre las principales causas de ceguera o baja visión. La mayoría de la población tiene o ha tenido algún trastorno ocular a lo largo de su vida. Según el informe de la Organización Mundial de la Salud (OMS) \"Ceguera y discapacidad visual\" publicado en febrero de 2021, alrededor de 2.200 millones de personas en todo el mundo tienen discapacidad visual de cerca o de lejos. También se ha estimado que la principal causa de pérdida de visión o baja visión son las cataratas (94 millones) y los errores refractivos no corregidos (88,4 millones). Además, las otras causas comunes de pérdida de visión son el glaucoma (7,7 millones), las opacidades corneales (4,2 millones), la retinopatía diabética (3,9 millones) y el tracoma (2 millones). Según el Real Instituto Nacional de Personas Ciegas en 2017, en el Reino Unido había alrededor de 350.000 personas registradas como ciegas y con discapacidad visual; alrededor de 173.735 estaban registrados como personas con discapacidad visual grave; y 176.125 se registraron como personas con discapacidad visual. Por lo tanto, la creciente prevalencia de trastornos oculares está impulsando el mercado de administración de fármacos oculares.

Segmentos de mercado clave

Fármacos oculares en Europa El mercado de entrega está segmentado según la tecnología, el tipo de formulación, el tipo de enfermedad y el usuario final. Según la tecnología, el segmento de sistemas implantables de administración de fármacos oculares representó la participación más alta en 2021. Según el tipo de formulación, el segmento de soluciones representó la participación más alta en 2021. Según el tipo de enfermedad, el segmento de cataratas representó la participación más alta en 2021. Según El segmento de hospitales de usuarios finales representó la mayor proporción en 2021.

Principales fuentes y empresas incluidas

Algunas importantes fuentes primarias y Las fuentes secundarias a las que se hace referencia para preparar este informe sobre el mercado de administración de fármacos oculares en Europa son los sitios web de las empresas, los informes anuales, los informes financieros, los documentos de los gobiernos nacionales y las bases de datos estadísticas, entre otros. Las principales empresas que figuran en el informe son AbbVie Inc.; Bausch Health Companies Inc.; Novartis AG; Clearside Biomédica, Inc.; Envisia Terapéutica; GRAYBUG VISION, INC entre otros.

Informe de razones para comprar

Ahorre y reduzca el tiempo al realizar investigaciones de nivel inicial identificando el crecimiento, el tamaño, los principales actores y segmentos en el mercado europeo de administración de fármacos oculares
Clave destacada prioridades comerciales para ayudar a las empresas a realinear sus estrategias comerciales
Los hallazgos y recomendaciones clave destacan las tendencias progresivas cruciales de la industria en el mercado europeo de administración de medicamentos oculares, lo que permite a los actores de toda la cadena de valor desarrollar estrategias efectivas a largo plazo.
Desarrollar/modificar planes de expansión empresarial utilizando una oferta de crecimiento sustancial en mercados desarrollados y emergentes.
Examinar en profundidad las tendencias y perspectivas del mercado europeo, junto con los factores que impulsan también el mercado de administración de fármacos oculares. como aquellos que lo obstaculizan
Mejorar el proceso de toma de decisiones mediante la comprensión de las estrategias que sustentan el interés comercial con respecto a los productos, la segmentación, los precios y la distribución de los clientes

Segmentación del mercado europeo de administración de fármacos oculares

Mercado europeo de administración de fármacos oculares: Por tecnología

Sistemas oculares implantables de administración de fármacos
Sistemas de administración de fármacos en partículas
Sistema de administración de fármacos con nanopartículas
Otros

< span>Mercado europeo de administración de fármacos oculares: Por tipo de formulación

Solución
Ungüento
Suspensión
Emulsión
Liposomas y Nanopartículas

< p>Mercado europeo de administración de fármacos oculares: Por tipo de enfermedad

EuropaMercado de administración de fármacos oculares: Por usuario final

Hospitales
Clínicas oftálmicas
Centros de cirugía ambulatoria

Mercado europeo de administración de fármacos oculares: Por país

Mercado europeo de administración de fármacos oculares: Empresas mencionadas

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Ocular Drug Delivery Market – By Technology

1.3.2 Europe Ocular Drug Delivery Market – By Formulation Type

1.3.3 Europe Ocular Drug Delivery Market – By Disease Type

1.3.4 Europe Ocular Drug Delivery Market – By End User

1.3.5 Europe Ocular Drug Delivery Market – By Country

2. Europe Ocular Drug Delivery Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Ocular Drug Delivery Market – Market Landscape

4.1 Overview

4.2 Expert Opinions

5. Europe Ocular Drug Delivery Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging Prevalence of Eye Disorders

5.2 Market Restraints

5.2.1 Drawbacks Associated with Ocular Drug Delivery

5.3 Market Opportunities

5.3.1 Raising Awareness About Vision Care

5.4 Future Trends

5.4.1 Emergence of Innovative Products

5.5 Impact analysis

6. Europe Ocular Drug Delivery – Market Analysis

6.1 Europe Ocular Drug Delivery Market Revenue Forecast and Analysis

7. Europe Ocular Drug Delivery Market Analysis – By Technology

7.1 Overview

7.2 Europe Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

7.3 Implantable Ocular Drug Delivery Systems

7.3.1 Overview

7.3.2 Implantable Ocular Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.4 Particulate Drug Delivery Systems

7.4.1 Overview

7.4.2 Particulate Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.5 Nano-Particle Drug Delivery System

7.5.1 Overview

7.5.2 Nano-Particle Drug Delivery System Market Revenue and Forecast to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

8. Europe Ocular Drug Delivery Market Analysis – By Formulation Type

8.1 Overview

8.1.1 Europe Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

8.2 Liposomes and Nanoparticles Market

8.2.1 Overview

8.2.2 Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

8.3 Solution

8.3.1 Overview

8.3.2 Solution Market Revenue and Forecasts to 2028 (US$ Million)

8.4 Emulsion

8.4.1 Overview

8.4.2 Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

8.5 Suspension

8.5.1 Overview

8.5.2 Suspension Market Revenue and Forecasts to 2028 (US$ Million)

8.6 Ointment

8.6.1 Overview

8.6.2 Ointment Market Revenue and Forecasts to 2028 (US$ Million)

9. Europe Ocular Drug Delivery Market Analysis – By Disease Type

9.1 Overview

9.2 Europe Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

9.3 Cataract

9.3.1 Overview

9.3.2 Cataract Market Revenue and Forecast to 2028 (US$ Million)

9.4 Dry Eye Syndrome

9.4.1 Overview

9.4.2 Dry Eye Syndrome Market Revenue and Forecast to 2028 (US$ Million)

9.5 Macular Degeneration

9.5.1 Overview

9.5.2 Macular Degeneration Market Revenue and Forecast to 2028 (US$ Million)

9.6 Glaucoma

9.6.1 Overview

9.6.2 Glaucoma Market Revenue and Forecast to 2028 (US$ Million)

9.7 Diabetic Retinopathy

9.7.1 Overview

9.7.2 Diabetic Retinopathy Market Revenue and Forecast to 2028 (US$ Million)

9.8 Diabetic Macular Edema

9.8.1 Overview

9.8.2 Diabetic Macular Edema Market Revenue and Forecast to 2028 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Ocular Drug Delivery Market Analysis – By End User

10.1 Overview

10.2 Europe Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.4 Ophthalmic Clinics

10.4.1 Overview

10.4.2 Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.5 Ambulatory Surgical Centers

10.5.1 Overview

10.5.2 Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

11. Europe Ocular Drug Delivery Market – Country Analysis

11.1 Overview

11.1.1 Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Country (%)

11.1.1.1 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.1 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.2 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.1.3 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.1.4 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.1.5 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.2 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.1 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.2 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.2.3 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.2.4 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.2.5 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.3 France Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.1 France Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.2 France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.3.3 France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.3.4 France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.3.5 France Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.4 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.1 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.2 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.4.3 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.4.4 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.4.5 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.5 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.5.1 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.5.2 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.5.3 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.5.4 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.5.5 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.6 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.6.1 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.6.2 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.6.3 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.6.4 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.6.5 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

12. Impact Of COVID-19 Pandemic on Europe Ocular Drug Delivery Market

12.1 Impact Assessment of COVID-19 Pandemic

13. Industry Landscape

13.1 Overview

13.2 Organic Developments

13.2.1 Overview

13.3 Inorganic Developments

13.3.1 Overview

14. Company Profiles

14.1 AbbVie Inc.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Bausch Health Companies Inc.

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 GRAYBUG VISION, INC.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Alimera Sciences, Inc.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Novartis AG

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Clearside Biomedical, Inc.

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology US$ Million)

Table 2. Germany and Middle East and Africa Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million).

Table 3. Germany and Middle East and Africa Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million).

Table 4. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User US$ Million)

Table 5. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology US$ Million)

Table 6. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million).

Table 7. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million).

Table 8. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User US$ Million)

Table 9. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 10. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 11. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 12. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

Table 13. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 14. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 15. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 16. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

Table 17. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 18. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 19. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 20. Spain Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 by End User (USD Million)

Table 21. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 22. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 23. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 24. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

Table 25. Organic Developments Done By Companies

Table 26. Inorganic Developments Done by Companies

Table 27. Glossary of Terms, Ocular Drug Delivery Market

LIST OF FIGURES

Figure 1. Europe Ocular Drug Delivery Market Segmentation

Figure 2. Europe Ocular Drug Delivery Market Segmentation, By Country

Figure 3. Europe Ocular Drug Delivery Market Overview

Figure 4. Implantable Ocular Drug Delivery Systems Segment Held the Largest Share of the Technology Segment in Ocular Drug Delivery Market

Figure 5. The UK to Show Significant Growth During Forecast Period

Figure 6. Europe Ocular Drug Delivery Market, Industry Landscape

Figure 7. Europe PEST Analysis

Figure 8. Europe Ocular Drug Delivery Market Impact Analysis of Driver and Restraints

Figure 9. Europe Ocular Drug Delivery Market – Revenue Forecast and Analysis – 2020- 2028

Figure 10. Europe Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

Figure 11. Implantable Ocular Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Particulate Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Nano-Particle Drug Delivery System Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. Europe Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

Figure 16. Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Solution Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Suspension Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Ointment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Europe Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

Figure 22. Cataract Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Dry Eye Syndrome Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Macular Degeneration Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Glaucoma Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Diabetic Retinopathy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. Diabetic Macular Edema Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29. Europe Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

Figure 30. Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 32. Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 33. Europe: Ocular Drug Delivery Market Revenue Overview, by Country, 2021 (US$ MILLION)

Figure 34. Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Country (%)

Figure 35. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37. France Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 38. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 39. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 40. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 41. Impact of COVID-19 Pandemic in European Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe ocular drug delivery market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in Europe ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the ocular drug delivery market as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample